Straits Times Index
3,343.35 +11.65 (+0.35%) S&P 500
5,482.87 +4.97 (+0.09%) Dow
39,164.06 +36.26 (+0.09%) Nasdaq
17,858.68 +53.53 (+0.30%) Bitcoin USD
61,441.12 +469.14 (+0.77%) CMC Crypto 200
1,281.85 +15.70 (+1.24%)
TNDM Nov 2024 42.500 call
- Business Wire
Tandem Mobi Improves Quality of Life for People Living With Type 1 Diabetes in New Data Shared at American Diabetes Association Scientific Sessions
SAN DIEGO, June 22, 2024--Tandem Diabetes Care today presented positive real-world data from a Tandem Mobi user satisfaction survey at the 2024 ADA Scientific Sessions.
- Business Wire
Tandem Diabetes Care Appoints Jean-Claude Kyrillos as Chief Operating Officer
SAN DIEGO, June 20, 2024--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Jean-Claude "JC" Kyrillos as Executive Vice President and Chief Operating Officer, effective June 21, 2024. Mr. Kyrillos comes to Tandem with more than 20 years of global executive leadership experience in medical device, digital health, and healthcare management.
- Business Wire
Tandem Diabetes Care to Present New Early User Insights on the Tandem Mobi System at the American Diabetes Association’s 84th Scientific Sessions
SAN DIEGO, June 18, 2024--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced its schedule of presentations for the American Diabetes Association’s (ADA) 84th Scientific Sessions taking place in Orlando, Florida from June 21-24.
